Asia Media News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Media News.

Press releases published on September 3, 2026

Sep. 3, 2026

Wood Mackenzie: Natural Carbon Sinks Absorb 40% of Human CO2 Emissions and Are Not Valued in Most Climate Models

Indeterminate GlobeNewswire

Sep. 3, 2026

Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Aduro Clean Technologies fait le point sur ses activités et publie ses résultats pour le quatrième trimestre et l’exercice 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Aduro Clean Technologies gibt Ergebnisse für das vierte Quartal und das Geschäftsjahr 2026 bekannt und informiert über den aktuellen Geschäftsverlauf

Indeterminate GlobeNewswire

Sep. 3, 2026

Tierfreie Rohstoffe von Nu-Tek BioSciences treiben die Weiterentwicklung von Zellkulturmedien und die Versorgungssicherheit auf der CPHI Global 2026 in Mailand voran

Indeterminate GlobeNewswire

Sep. 3, 2026

Nu-Tek au salon CPHI Global 2026 à Milan : les matières premières sans composants d’origine animale de Nu-Tek BioSciences favorisent l’évolution des milieux de culture cellulaire et la sécurité d’approvisionnement

Indeterminate GlobeNewswire

Sep. 3, 2026

Oligonucleotide Drug Delivery Is Moving Beyond the Liver

Indeterminate GlobeNewswire

Sep. 3, 2026

Nu-Tek BioSciences’ Animal-Free Raw Materials Drive Cell Culture Media Evolution, Supply Security at CPHI Global 2026 in Milan

Indeterminate GlobeNewswire

Sep. 3, 2026

BlossomHill Therapeutics to Present at the 8th Annual RAS-Targeted Drug Development Summit & H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting

Indeterminate GlobeNewswire

Sep. 3, 2026

Fate Therapeutics to Participate in Fireside Chat at the 2026 Annual Cantor Global Healthcare Conference

Indeterminate GlobeNewswire

Sep. 3, 2026

Alternative Ballistics Appoints Sertan Ayçiçek to Help Drive Global Expansion, Strategic Investment and Commercial Growth

Indeterminate GlobeNewswire

Sep. 3, 2026

Aurora Mobile Showcases AI Solutions for Customer Engagement at Tokyo’s AI Expo Summer 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Gyre Therapeutics to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

ANI Pharmaceuticals to Present at September Investor Conferences

Indeterminate GlobeNewswire

Sep. 3, 2026

Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026

Indeterminate GlobeNewswire

Sep. 3, 2026

Virtune AB (Publ) (“Virtune”) has completed the monthly rebalancing for September 2026 of its Virtune Crypto Top 10 Index ETP - the first crypto index ETP in the Nordics

Indeterminate GlobeNewswire

Sep. 3, 2026

Virtune AB (Publ) (“Virtune”) har genomfört den månatliga rebalanseringen för september 2026 av Virtune Crypto Top 10 Index ETP, Nordens första kryptoindex-ETP

Indeterminate GlobeNewswire